mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.039 |
0.3 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.037 |
0.3 |
mRNA |
temsirolimus |
CTRPv2 |
pan-cancer |
AAC |
0.035 |
0.5 |
mRNA |
temsirolimus |
GDSC1000 |
pan-cancer |
AAC |
-0.012 |
0.7 |
mRNA |
temsirolimus |
FIMM |
pan-cancer |
AAC |
-0.047 |
0.8 |
mRNA |
thalidomide |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.8 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
-0.13 |
0.02 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
-0.041 |
0.2 |
mRNA |
tigecycline |
CTRPv2 |
pan-cancer |
AAC |
-0.061 |
0.2 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |